Dr. Vicky Lee

Dr. Vicky Lee, MD, PhD

Specialties and Expertise

Dr. Vicky Lee is a medical oncologist and hematologist with over 30 years of experience​, and she currently serves as Director of the Jiahui International Cancer Center (JICC) and Chief of Medical Oncology in Shanghai​. Her expertise spans solid tumor oncology – focusing on breast, melanoma, colon, and lung cancers – as well as hematologic malignancies such as multiple myeloma and lymphoma​. She also has experience in cancer genetic risk assessment and palliative care, including cancer pain management​.

Education and Training

Dr. Lee earned her medical degree from Shandong Medical University in China. She later pursued advanced research training in oncology in Japan and the United States​. She completed her specialist training in the U.S. and became board certified in internal medicine, hematology, and medical oncology in 1995​.

Professional Experience and Roles

Before joining Jiahui, Dr. Lee practiced oncology in the United States for over 20 years​. She served on the board of the Washington State Society of Medical Oncology and was active in professional societies. Now in Shanghai, she leads Jiahui’s oncology program as executive director of JICC, applying her global expertise to patient care​.

Patient Care Philosophy

Dr. Lee practices a patient-centered approach and applies the latest international standards in cancer treatment. She is skilled in treating rare and complex cancers and emphasizes clear communication with patients and families. Dr. Lee encourages patients to participate in treatment decisions, believing this collaboration improves understanding and outcomes. She also prioritizes quality of life by managing cancer pain and symptoms through individualized palliative care plans.

Languages and International Experience

Fluent in English and Mandarin​, Dr. Lee has trained and worked in China, Japan, and the United States, giving her an international perspective on patient care.

Dr. Vicky Lee is a highly experienced medical oncologist and hematologist, renowned for her comprehensive expertise in the diagnosis, treatment, and long-term management of both solid tumors and hematologic malignancies. With over three decades of clinical experience across China, Japan, and the United States, her specialties reflect a broad and integrative understanding of cancer care, tailored to both local and international patient populations.

🔬 Solid Tumor Oncology

Dr. Lee’s clinical focus includes the treatment of common and complex solid tumors such as:

• Breast cancer – one of her core areas of interest, where she applies the latest targeted therapies and hormonal treatments.

• Lung cancer – with experience in advanced non-small cell and small cell lung cancers.

• Colorectal cancer – using multimodal approaches including chemotherapy and biologics.

• Melanoma and other skin cancers – with particular skill in integrating immunotherapy and precision medicine approaches.

Her treatment strategies are evidence-based and personalized, often involving multidisciplinary team discussions to ensure optimal outcomes.

🩸 Hematologic Malignancies

Dr. Lee is also recognized for her work in:

• Lymphoma (Hodgkin and non-Hodgkin)

• Multiple Myeloma

• Chronic leukemias

She stays up to date with international treatment protocols, clinical trials, and emerging therapies, ensuring that patients benefit from the most current standards of care.

🧬 Cancer Genetics and Risk Assessment

Dr. Lee offers services in cancer genetic counseling, helping patients understand their inherited risk factors. This includes assessments for BRCA mutations and other hereditary cancer syndromes, enabling early detection and preventive strategies for at-risk individuals and families.

🧘 Palliative Care & Pain Management

She is also deeply committed to palliative oncology, focusing on relieving cancer-related pain and symptoms, improving quality of life at all stages of disease. Her approach integrates compassionate care with clinical excellence, ensuring that treatment aligns with the values and preferences of each patient.

🏥 Comprehensive Cancer Treatments by Dr. Vicky Lee

Dr. Vicky Lee offers an extensive range of advanced cancer treatments tailored to individual patient needs. Her approach integrates international best practices, precision medicine, and compassionate care.

🎯 1. Solid Tumor Treatments

🔹 Breast Cancer

• Hormonal therapy (e.g., tamoxifen, aromatase inhibitors)

• Targeted therapy (HER2 inhibitors such as trastuzumab)

• Chemotherapy (neoadjuvant and adjuvant)

• Immunotherapy (in specific subtypes)

• Post-treatment survivorship planning

🔹 Lung Cancer

• Platinum-based chemotherapy regimens

• Targeted therapy for EGFR, ALK, ROS1 mutations

• Immunotherapy (PD-1/PD-L1 inhibitors)

• Palliative radiation coordination for symptom control

🔹 Colorectal Cancer

• Systemic chemotherapy (FOLFOX, FOLFIRI)

• Targeted biologics (bevacizumab, cetuximab)

• Molecular profiling for precision treatment

• Surveillance post-surgery

🔹 Melanoma and Other Skin Cancers

• Immunotherapy (checkpoint inhibitors)

• Targeted BRAF/MEK inhibitors

• Supportive management for advanced disease

• TIL therapy

🩸 2. Hematologic Cancer Treatments

🔹 Lymphomas (Hodgkin and Non-Hodgkin)

• Chemotherapy (e.g., ABVD, R-CHOP)

• Targeted antibody therapy (rituximab, brentuximab)

• Stem cell transplant referral and coordination

• CAR T Cell therapy

🔹 Multiple Myeloma

• Proteasome inhibitors (bortezomib)

• Immunomodulatory agents (lenalidomide)

• Autologous stem cell transplant evaluation

• CAR T Cell therapy

• Maintenance therapy

🔹 Leukemias (Chronic and Acute)

• Oral targeted therapies (e.g., imatinib for CML)

• Intensive chemotherapy (in selected cases)

• CAR T-Cell therapy

• Long-term monitoring and response assessment

🧬 3. Genetic Risk Assessment & Preventive Oncology

• BRCA1/2 mutation screening

• Lynch syndrome testing

• Family history-based cancer risk evaluations

• Preventive strategies for high-risk individuals

💊 4. Supportive & Palliative Care

• Advanced cancer pain management (opioid and non-opioid)

• Symptom control (nausea, fatigue, neuropathy)

• Psychosocial support and end-of-life planning

• Integration of palliative care with active treatment

Dr. Lee believes in multidisciplinary collaboration and empowers her patients with clear information to make informed decisions. Her treatments are tailored, compassionate, and guided by the latest global standards.

Research and Publications of Dr. Vicky Lee

Peer-Reviewed Publications

• Frontiers in Oncology (2018) – Co-authored “nab-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC.” This Phase IV trial publication evaluated chemotherapy (nab-paclitaxel/carboplatin) in elderly lung cancer patients. Dr. Vicky Lee served as a site investigator and was listed among the collaborating authors.
• Cancer Research & Clinical Studies (1990s) – During her PhD training, Dr. Lee focused on breast cancer biology and cancer immunology. Her early research helped lay the foundation for her specialization in breast oncology.

Clinical Trial Involvement

• CAR-T Therapy in Hematologic Malignancies – Led the treatment of the first multiple myeloma patient with CAR-T cell therapy at Jiahui (2022).
• Breast Cancer Trials – Participating investigator in the B-STRONGER-I and Elegant Phase III trials focusing on breast cancer detection and treatment.
• Other Oncology Trials – Contributed to studies across oncology, including advanced lung cancer and biomarker-driven therapies.

Conference Presentations and Invited Lectures

• Northwest Women’s Cancer Conference (2022) – Co-led breast cancer management sessions.
• International CAR-T Symposium (2023) – Chaired panels and led discussions on CAR-T therapy.
• Annual Scientific Meeting – Malaysian Society of Transplantation (2025) – Spoke on CAR-T therapy in hematology and transplantation.

Key Research and Clinical Focus Areas

• Breast Cancer – Strong research focus and clinical trial contributions, including work on genetic risk and recurrence prevention.
• Hematologic Malignancies – Leader in CAR-T therapy implementation and hematologic oncology trials.
• Cancer Pain Management and Palliative Care – Developed protocols and educational sessions on cancer pain control.
• Cancer Genetics and Risk Assessment – Trained at City of Hope, launched genetic counseling services at Jiahui.